Reduced acetylcholine receptors in myasthenia gravis.
D000109:Acetylcholine; D002038:Bungarotoxins / Q000494:pharmacology; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D006801:Humans; D007457:Iodine Radioisotopes; D009121:Muscle Denervation; D009132:Muscles / Q000294:innervation / Q000473:pathology; D009157:Myasthenia Gravis / Q000188:drug therapy / Q000473:pathology*; D009469:Neuromuscular Junction / Q000187:drug effects / Q000473:pathology*; D011984:Sensory Receptor Cells / Q000187:drug effects / Q000473:pathology*; D009435:Synaptic Transmission / Q000187:drug effects
D002038:Bungarotoxins; D002800:Cholinesterase Inhibitors; D007457:Iodine Radioisotopes; D000109:Acetylcholine